| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $801.2M | +14.0% |
| Cost of Revenue | $388.2M | +18.9% |
| Gross Profit | $413.0M | +9.8% |
| R&D Expense | $139.1M | +51.1% |
| SG&A Expense | $335.7M | +28.4% |
| Operating Income | -$92.8M | -509.9% |
| Pre-tax Income | -$92.9M | -683.9% |
| Income Tax | $1.7M | +420.0% |
| Net Income | -$94.6M |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $172.5M | +142.4% |
| Short-term Investments | $444.4M | -19.6% |
| Accounts Receivable | $114.7M | +3.6% |
| Inventory | $111.1M | +62.1% |
| Current Assets | $850.0M | +4.7% |
| Total Assets | $1.05B | +16.3% |
| Current Liabilities | $165.3M | +25.4% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $50.5M | -54.7% |
| Capital Expenditures | $34.1M | +140.5% |
| Investing Cash Flow | $33.2M | +117.7% |
| Financing Cash Flow | $16.9M | -67.5% |
| Free Cash Flow | $16.4M | -83.2% |
| -707.7% |
| EPS (Basic) | -$1.47 | -688.0% |
| EPS (Diluted) | -$1.47 | -712.5% |
| Total Liabilities |
| $612.8M |
| +29.8% |
| Stockholders' Equity | $439.9M | +1.6% |